NXSTAGE MEDICAL INC (NXTM) Stock Price & Overview

NASDAQ:NXTMUS67072V1035

Current stock price

30
+0.01 (+0.03%)
At close:
30
0 (0%)
After Hours:

The current stock price of NXTM is 30 null. Today NXTM is up by 0.03%. In the past month the price increased by 5.49%. In the past year, price increased by 27.71%.

NXTM Key Statistics

52-Week Range23.17 - 30
Current NXTM stock price positioned within its 52-week range.
1-Month Range28 - 30
Current NXTM stock price positioned within its 1-month range.
Market Cap
2.001B
P/E
N/A
Fwd P/E
136.36
EPS (TTM)
-0.08
Dividend Yield
N/A

NXTM Stock Performance

Today
+0.03%
1 Week
+2.85%
1 Month
+5.49%
3 Months
+3.16%
Longer-term
6 Months +5.71%
1 Year +27.71%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

NXTM Stock Chart

NXSTAGE MEDICAL INC / NXTM Daily stock chart

NXTM Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to NXTM. When comparing the yearly performance of all stocks, NXTM is one of the better performing stocks in the market, outperforming 87.3% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NXTM Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to NXTM. Both the profitability and the financial health of NXTM get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NXTM Earnings

Next Earnings DateN/A
Last Earnings DateN/A

NXTM Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y95.45%
Revenue Next YearN/A

NXTM Financial Highlights

Over the last trailing twelve months NXTM reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 61.9% compared to the year before.


Income Statements
Revenue(TTM)425.99M
Net Income(TTM)-5.50M
Industry RankSector Rank
PM (TTM) -1.29%
ROA -1.46%
ROE -2.44%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%107.14%
Sales Q2Q%11.13%
EPS 1Y (TTM)61.9%
Revenue 1Y (TTM)11.12%

NXTM Ownership

Ownership
Inst Owners0%
Shares66.69M
Float44.83M
Ins Owners0.08%
Short Float %N/A
Short RatioN/A

About NXTM

Company Profile

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.

Company Info

NXSTAGE MEDICAL INC

350 MERRIMACK STREET

LAWRENCE MA 01843

CEO: Jeffrey H. Burbank

Phone: 978-687-4700

NXSTAGE MEDICAL INC / NXTM FAQ

Can you describe the business of NXSTAGE MEDICAL INC?

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.


What is the stock price of NXSTAGE MEDICAL INC today?

The current stock price of NXTM is 30 null. The price increased by 0.03% in the last trading session.


Does NXSTAGE MEDICAL INC pay dividends?

NXTM does not pay a dividend.


What is the ChartMill technical and fundamental rating of NXTM stock?

NXTM has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Where is NXSTAGE MEDICAL INC (NXTM) stock traded?

NXTM stock is listed on the Nasdaq exchange.


Can you provide the market cap for NXSTAGE MEDICAL INC?

NXSTAGE MEDICAL INC (NXTM) has a market capitalization of 2.00B null. This makes NXTM a Mid Cap stock.


Who owns NXSTAGE MEDICAL INC?

You can find the ownership structure of NXSTAGE MEDICAL INC (NXTM) on the Ownership tab.